CIK: 0001475373 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 9, 2023
Total Value ($000): $446,932 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 601,367 | $46,347 | 10.4% | $56.33 | +28.9% | COM | 375558103 |
| CAH | CARDINAL HEALTH INC | 384,642 | $36,376 | 8.1% | $50.01 | +61.1% | COM | 14149Y108 |
| BMY | BRISTOL-MYERS SQUIBB CO | 507,576 | $32,459 | 7.3% | $51.10 | +15.3% | COM | 110122108 |
| MDT | MEDTRONIC PLC | 346,508 | $30,527 | 6.8% | $83.93 | -5.4% | SHS | G5960L103 |
| BIIB | BIOGEN INC | 95,757 | $27,276 | 6.1% | $271.71 | +9.6% | COM | 09062X103 |
| INCY | INCYTE CORP | 397,532 | $24,746 | 5.5% | $74.14 | -9.8% | COM | 45337C102 |
| BDX | BECTON DICKINSON & CO | 92,923 | $24,533 | 5.5% | $241.97 | 0.0% | COM | 075887109 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 148,812 | $21,667 | 4.8% | $115.00 | +15.4% | COM | 98956P102 |
| BAX | BAXTER INTL INC | 473,634 | $21,579 | 4.8% | $45.42 | -10.3% | COM | 071813109 |
| EW | EDWARDS LIFESCIENCES CORP | 195,291 | $18,422 | 4.1% | $78.91 | +10.1% | COM | 28176E108 |
| — | LABORATORY CORP AMER HLDGS | 73,104 | $17,642 | 3.9% | $234.97 | — | COM NEW | 50540R409 |
| CNC | CENTENE CORP DEL | 244,949 | $16,522 | 3.7% | $67.45 | -1.1% | COM | 15135B101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 162,668 | $14,100 | 3.2% | $85.88 | +9.6% | COM | 09061G101 |
| ELV | ELEVANCE HEALTH INC | 31,351 | $13,929 | 3.1% | $311.68 | +42.0% | COM | 036752103 |
| THC | TENET HEALTHCARE CORP | 161,457 | $13,139 | 2.9% | $46.22 | +54.0% | COM NEW | 88033G407 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 151,328 | $12,294 | 2.8% | $79.45 | 0.0% | COMMON STOCK | 36266G107 |
| — | NUVASIVE INC | 266,370 | $11,078 | 2.5% | $51.32 | — | COM | 670704105 |
| BRKR | BRUKER CORP | 112,242 | $8,297 | 1.9% | $52.55 | +43.6% | COM | 116794108 |
| — | CATALENT INC | 180,088 | $7,809 | 1.7% | $55.72 | — | COM | 148806102 |
| IONS | IONIS PHARMACEUTICALS INC | 160,401 | $6,581 | 1.5% | $52.29 | -26.5% | COM | 462222100 |
| — | AMEDISYS INC | 71,007 | $6,493 | 1.5% | $91.44 | — | COM | 023436108 |
| — | QIAGEN NV | 127,526 | $5,742 | 1.3% | $49.46 | — | SHS NEW | N72482123 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 28,067 | $5,331 | 1.2% | $209.91 | -5.6% | COM | 02043Q107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 200,696 | $4,807 | 1.1% | $16.32 | +36.2% | COM | 004225108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 100,605 | $4,641 | 1.0% | $54.33 | -14.6% | COM | 90400D108 |
| JNJ | JOHNSON & JOHNSON | 26,471 | $4,381 | 1.0% | $148.89 | 0.0% | COM | 478160104 |
| LNTH | LANTHEUS HLDGS INC | 50,309 | $4,222 | 0.9% | $89.74 | 0.0% | COM | 516544103 |
| VIR | VIR BIOTECHNOLOGY INC | 150,406 | $3,689 | 0.8% | $29.24 | -14.1% | COM | 92764N102 |
| PTCT | PTC THERAPEUTICS INC | 56,577 | $2,301 | 0.5% | $38.85 | +25.9% | COM | 69366J200 |